Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 3.3mm NC, SLA? 12mm, Ti, Loxim: medical device reports filed with FDA

2,134 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,134
device reports naming the brand
0% of all MAUDE reports · about 313 a year
383
reports, 12 months to August 2026
532 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

2,134 medical device reports received by FDA name the brand "BL, ? 3.3mm NC, SLA? 12mm, Ti, Loxim" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

383 reports arrived in the 12 months to August 2026, down 28% from 532 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (88.2%), loss of osseointegration (8.7%) and fracture (1.7%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

074147Sep 2021: 6Oct 2021: 16Nov 2021: 14Dec 2021: 112022Jan 2022: 22Feb 2022: 10Mar 2022: 20Apr 2022: 13May 2022: 7Jun 2022: 7Jul 2022: 16Aug 2022: 8Sep 2022: 2Oct 2022: 29Nov 2022: 19Dec 2022: 202023Jan 2023: 9Feb 2023: 7Mar 2023: 6Apr 2023: 19May 2023: 46Jun 2023: 54Jul 2023: 45Aug 2023: 29Sep 2023: 52Oct 2023: 32Nov 2023: 56Dec 2023: 622024Jan 2024: 28Feb 2024: 46Mar 2024: 38Apr 2024: 45May 2024: 43Jun 2024: 50Jul 2024: 46Aug 2024: 36Sep 2024: 50Oct 2024: 28Nov 2024: 42Dec 2024: 472025Jan 2025: 35Feb 2025: 23Mar 2025: 48Apr 2025: 35May 2025: 0Jun 2025: 147Jul 2025: 35Aug 2025: 42Sep 2025: 66Oct 2025: 19Nov 2025: 44Dec 2025: 322026Jan 2026: 31Feb 2026: 27Mar 2026: 9Apr 2026: 40May 2026: 17Jun 2026: 28Jul 2026: 42Aug 2026: 28

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02635262019: 8120192020: 8820202021: 12820212022: 17320222023: 41720232024: 49920242025: 52620252026: 2222026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,134
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report98.7%2,107
Voluntary report0%0
User facility report0%0
Distributor report1.3%27
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,88388.2%62.8%
Loss of osseointegration1858.7%22.4%
Fracturea broken bone371.7%1.6%
Difficult to insertthe device was hard to insert20.1%0.4%
Separation failure20.1%0.1%
Unstable20.1%0%
Therapeutic or diagnostic output failure10%0%
Unintended movement10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis29113.6%
Painpain, site not specified1517.1%
Inflammationinflammation1446.7%
Tissue damage1115.2%
Swelling/ edema542.5%
Hemorrhage/blood loss/bleeding442.1%
Numbnessnumbness190.9%
Abscessa collection of pus160.7%
Hyperresponsive to stimuli150.7%
Fistula120.6%
Failure of implant110.5%
Swellingswelling60.3%
Hypersensitivity/allergic reaction30.1%
Inadequate osseointegration30.1%
Increased sensitivity20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 3.3mm NC, SLA? 12mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports2,1343,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer98.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 3.3mm NC, SLA? 12mm, Ti, Loxim reports

How many FDA reports name BL, ? 3.3mm NC, SLA? 12mm, Ti, Loxim?

2,134 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 383 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (88.2%), loss of osseointegration (8.7%), fracture (1.7%), difficult to insert (0.1%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98.7%) and distributor reports (1.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 3.3mm NC, SLA? 12mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.